Jump to: What are GLP-1 receptor agonists? | Semaglutide and liraglutide for weight loss and type 2 diabetes | Ozempic VS Saxenda | Take home message
Ozempic® is more effective for weight loss and blood sugar improvements than Saxenda®. Studies have also shown that Ozempic® leads to fewer side effects and adverse events than Saxenda® with people tolerating Ozempic® better.
So, if you’re looking for a GLP-1 receptor agonist to help you lose weight and improve your blood sugar levels, Ozempic® is the better option.
However, individual responses to medications vary between individuals. Be mindful of side effects and contact your healthcare team to determine the appropriate medication and dosage.
What are Ozempic® and Saxenda®?
Ozempic® and Saxenda® are GLP-1 receptor agonists, a class of medications that reduce appetite to help manage blood sugar levels and support weight loss from the pharmaceutical company Novo Nordisk.
The active ingredient in Ozempic® is semaglutide, and liraglutide in Saxenda®. GLP-1 receptor agonists improve insulin function to lower blood sugar levels and delay gastric emptying, decreasing appetite.
Ozempic® has been approved for use in the UK and FDA-approved in the U.S. as a medication for type 2 diabetes, as it improves insulin action to manage blood sugar levels alongside its positive effect on appetite.
Saxenda® is approved for individuals living with obesity to help them eat fewer calories and lose weight. Still, you’ll also experience improved glycemic control due to the effect of GLP-1s on insulin function.
Initially approved as prescription drugs, they are now widely available online for private purchase in the U.S. and the UK.
One of the main differences between Ozempic® and Saxenda® is the dosing schedule. Both drugs are self-administered injections, but Ozempic® is administered once a week and Saxenda® once a day.
Saxenda® is available to purchase in the UK and U.S. and via prescription from your GP in the UK.
Ozempic® is available to purchase in the U.S. and UK and via prescription from your GP in the UK if you have a high BMI and are at risk of type 2 diabetes.
Not a magic pill
These medications are designed as additional tools for weight management interventions and shouldn’t be considered lifelong medications.
Instead, they should be used to help you kickstart your weight loss and healthy journey while you commit to living a healthier lifestyle.
At Second Nature, we’ve been trusted by the NHS since 2017 to support people with type 2 diabetes and obesity to lose weight and manage their blood sugar levels and lead healthier lifestyles for the long term.
If you’re considering purchasing Ozempic® or Saxenda® but need support in making positive changes to your lifestyle, Second Nature could be an option for you.
In 2022, the NHS published data in the BMJ that compared the weight loss outcomes of five providers in the National Diabetes Prevention Programme.
Second Nature was more than twice as effective at supporting weight loss than the other four providers.
You can also learn more about our new GLP-1 programme from our CEO, Chris.
Otherwise, keep reading as we dig into the science of Ozempic® and Saxenda® and how GLP-1s work.